Screener
West Pharmaceutical Services WST EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's EBITDA margin?
- West Pharmaceutical Services (WST) reported EBITDA margin of 25.9% in Q2 2026.
- How has West Pharmaceutical Services's EBITDA margin changed year-over-year?
- West Pharmaceutical Services's EBITDA margin increased by 3.1% year-over-year, from 25.1% to 25.9%.
- What is the long-term trend for West Pharmaceutical Services's EBITDA margin?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's EBITDA margin has grown at a 0.6% compound annual growth rate (CAGR), from 23.8% to 24.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about West Pharmaceutical Services's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude